Characterization of lineage-specific chimaerism in patients with acute leukaemia and myelodysplastic syndrome after allogeneic stem cell transplantation before and after relapse

British Journal of Haematology

Volumn 108, Issue 4, 2000, Pages 761-768

  Bader, P ^a   Stoll, K ^a   Huber, S ^a   Geiselhart, A ^a   Handgretinger, R ^a   Niemeyer, C ^b   Einsele, H ^a   Schlegel, P G ^a   Niethammer, D ^a   Beck, J ^c   Klingebiel, T ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

^c University Children's Hospital   (Germany)

Author keywords

Acute leukaemia; Haematopoietic chimaerism; Relapse; Stem cell transplantation

Indexed keywords

ACUTE LEUKEMIA; ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; CELL PROLIFERATION; CHIMERA; CLINICAL ARTICLE; GRAFT VERSUS HOST REACTION; HEMATOPOIESIS; HIGH RISK PATIENT; HUMAN; MONONUCLEAR CELL; MYELODYSPLASTIC SYNDROME; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RELAPSE; RISK ASSESSMENT;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INFANT; LEUKEMIA, LYMPHOCYTIC, ACUTE, L1; LEUKEMIA, MYELOCYTIC, ACUTE; MIDDLE AGED; MYELODYSPLASTIC SYNDROMES; RECURRENCE; TIME FACTORS; TRANSPLANTATION CHIMERA; TRANSPLANTATION, HOMOLOGOUS;

EID: 0034084912     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.2000.01927.x     Document Type: Article

References (35)

1. Adams, D.H. & Hutchinson, I.V. (1997) Microchimerism and graft tolerance: cause or effect? Lancet, 349, 1336-1337.
2. Armitage, J. (1994) Bone marrow transplantation. New England Journal of Medicine, 330, 827-838.
3. Bader, P., Hölle, W., Klingebiel, T., Handgretinger, R., Niethammer, D. & Beck, J. (1996) Quantitative assessment of mixed hematopoietic chimerism by polymerase chain reaction after allogeneic BMT. Anticancer Research, 16, 1759-1763.
4. Baden, P., Hölle, W., Klingebiel, T., Handgretinger, R., Benda, N., Schlegel, P., Niethammer, D. & Beck, J. (1997) Mixed hematopoietic chimerism after allogeneic bone marrow transplantation: the impact of quantitative PCR analysis for prediction of relapse and graft rejection in children. Bone Marrow Transplantation, 19, 697-702.
5. Bader, P., Beck, J., Frey, A., Schlegel, P.G., Hebarth, H., Handgretinger, R., Einsele, H., Niemeyer, C., Benda. N., Faul, C., Kanz, L., Niethammer, D. & Klingebiel, T. (1998) Serial and quantitative analysis of mixed hematopoietic chimerism by PCR in patients with acute leukemias allows the prediction of relapse after allogeneic BMT. Bone Marrow Transplantation, 21, 487-495.
6. Bertheas, M.F., Lafage. M., Levy, P., Blaise, D., Stoppa, A.M., Viens, P., Mannoni, P. & Maraninchi, D. (1991) Influence of mixed chimerism on the results of allogeneic bone marrow transplantation for leukemia. Blood, 78, 3103-3106.
7. Dermine, S., Mavroudis, D., Jiang, Y.Z., Hensel, N., Molldrem, J. & Barrett, A.J. (1997) Immune escape from a graft-versus-leukemia effect may play a role in the relapse of myeloid leukemias following allogeneic bone marrow transplantation. Bone Marrow Transplantation, 19, 989-999.
8. Elwood, E.T., Larsen, C.P., Maurer, D.H., Routenberg, K.L., Neylan, J.F., Whelchel, J.D., O'Brien, D.P. & Pearson, T.C. (1997) Microchimerism and rejection in clinical transplantation. Lancet. 349, 1358-1360.
9. Gardiner, N., Lawler, M., O'Riordan, J., De'Arce, M. & McCann, S.R. (1997) Donor chimaerism is a strong indicator of disease free survival following bone marrow transplantation for chronic myeloid leukaemia. Leukemia, 11, 512-515.
10. Gardiner, M., Lawler, M., O'Riordan, J.M., Duggan, C., De'Arce, M. & McCann, S.R. (1998) Monitoring of lineage-specific chimaerism allows early prediction of response following donor lymphocyte infusions for relapsed chronic myeloid leukemia. Bone Marrow Transplantation, 21, 711-719.
11. Hancock, J., Burgess, M., Goulden, N., Ferris, V. Steward, C., Potter, M. & Oakhill, A. (1996) Prediction of relapse following unrelated BMT for childhood acute lymphoblastic leukaemia by serial analysis of early chimerism. Blood, 88 (Suppl. 1), 268a.
12. Hill, R.S., Petersen, F.B., Storb, R., Appelbaum, F.R., Doney, K., Dahlberg, S., Ramberg, R. & Thomas, E.D. (1986) Mixed hematologic chimerism after allogeneic marrow transplantation for severe aplastic anemia is associated with a higher risk of graft rejection and a lessened incidence of acute graft-versus-host disease. Blood, 67, 811-816.
13. Jankowski, R.A. & Ildstad, S.T. (1997) Chimerism and tolerance: from freemartin cattle and neonatal mice to humans. Human Immunology, 52, 155-161.
14. Lawler, M., Humphries, P. & McCann, S.R. (1991) Evaluation of mixed chimerism by in vitro amplification of dinucleotide repeat sequences using the polymerase chain reaction. Blood, 77, 2504-2514.
15. van Leeuwen, J.E., van Tol, M.J., Joosten, A.M., Wijnen, J.T., Verweij. P.J., Khan, P.M. & Vossen, J.M. (1994) Persistence of host-type hematopoiesis after allogeneic bone marrow transplantation for leukemia is significantly related to the recipient's age and/or the conditioning regimen, but it is not associated with an increased risk of relapse. Blood, 83, 3059-3067.
16. Mackinnon, S., Papadopoulos, E.B., Carabasi, M.H., Reich, L., Collins, N.H., Boulad, F., Castro Malaspina, H., Childs, B.H., Gillio, A.P., Kernan, N.A., Small, T.N., Young, J.W. & O'Reilly, R.J. (1995) Adoptive immunotherapy evaluating escalating doses of donor leukocytes for relapse of chronic myeloid leukemia after hone marrow transplantation: separation of graft-versus-leukemia responses from graft-versus-host disease. Blood, 86, 1261-1268.
17. Mackinnon, S., Barnett, L. & Heller, G. (1996) Polymerase chain reaction is highly predictive of relapse in patients following T cell-depleted allogeneic bone marrow transplantation for chronic myeloid leukemia. Bone Marrow Transplantation, 17, 643-647.
18. Martinelli, G., Trabetti, E., Zaccaria, A., Farabegoli, P., Buzzi, M., Testoni, N., Calori, E., Bandini, G., Rosti, G., Belardinelli, A., Gasparini, P., Galavotti, R., Ambrosetti, A., Tura, S. & Pignatti. P.F. (1993) In vitro amplification of hypervariable UNA regions for the evaluation of chimerism after allogeneic BMT. Bone Marrow Transplantation, 12, 115-120.
19. McCann, S. & Lawler, M. (1993) Mixed chimerism: detection and significance following BMT. Bone Marrow Transplantation, 11, 91-94.
20. Min, G., Hibbin, J., Arthur, C., Apperley, J., Jeffreys, A. & Goldman, J. (1988) Use of minisatellite DNA probes for recognition and characterization of relapse after allogeneic bone marrow transplantation. British Journal of Haematology, 68, 195-201.
21. Molloy, K., Goulden, N., Lawler, M., Cornish, J., Oakhill, A., Pamphilon, D., Potter, M., Steward. C., Langlands, K., Humphries, P. & McCann, S.R. (1996) Patterns of hematopoietic chimerism following bone marrow transplantation for childhood acute lymphoblastic leukemia from volunteer unrelated donors. Blood, 87, 3027-3031.
22. Nikolic, B. & Sykes, M. (1997) Bone marrow chimerism and transplantation tolerance. Current Opinions in Immunology, 9, 634-640.
23. Offit, K., Burns, J.P., Cunningham, I., Jhanwar, S.C., Black, P., Kernan, N.A., O'Reilly, R.J. & Chaganti, R.S. (1990) Cytogenetic analysis of chimerism and leukemia relapse in chronic myelogenous leukemia patients after T cell-depleted bone marrow transplantation. Blood, 75, 1346-1355.
24. Petit, T., Raynal, B., Socié, G., Landman-Parker, J., Bourhis, J., Gluckman, E., Pico, J. & Brison, O. (1994) Highly sensitive polymerase chain reaction methods show the frequent survival of residual recipient multipotent progenitors after non-T-cell-depleted bone marrow transplantation. Blood, 84, 3575-3583.
25. Petz, L.D., Yam. P., Wallace, R.B., de Stock, A.D., Lange, G., Knowlton, R.G., Brown, V.A., Donis Keller, H., Hill, L.R., Forman, S.J. & Blume, K.G. (1987) Mixed hematopoietic chimerism following bone marrow transplantation for hematologic malignancies. Blood, 70, 1331-1337.
26. Porter, D.L., Roth, M.S., McGarigle, C., Ferrara, J.L. & Antin, J.H. (1994) Induction of graft-versus-host disease as immunotherapy for relapsed chronic myeloid leukemia. New England Journal of Medicine, 330, 100-106.
27. Ramìrez, M., Dìaz, M., García-Sánchez, F., Velasco, M., Casado. F., Villa, M., Vicario, J. & Madero, L. (1996) Chimerism after allogeneic hematopoietic cell transplantation in childhood acute lymphoblastic leukemia. Bone Marrow Transplantation, 18, 1161-1165.
28. Rivera, G., Pinkel, D., Simone, J., Hancock, M. & Crist, W. (1993) Treatment of acute lymphoblastic leukemia: 30 years' experience at St. Jude Children's Research Hospital. New England Journal of Medicine, 329, 1289-1295.
29. Roux, E., Abdi, K., Speiser, D., Helg, C., Chapuis, B., Jeannet, M. & Roosnek, E. (1993) Characterisation of mixed chimerism in patients with chronic myeloid leukemia transplanted with T-cell-depleted bone marrow: involvement of different hematologic lineages before and after relapse. Blood, 81, 243-248.
30. Roux, E., Helg, C., Chapius, B., Jeannet, M. & Roosnek, E. (1994) Mixed chimerism after bone marrow transplantation and the risk of relapse [Letter]. Blood, 84, 4385-4386.
31. Roy, D.C., Tantravahi, R., Murray, C., Dear, K., Gorgone, B., Anderson, K.C., Freedman, A.S., Nadler, L.M. & Ritz, J. (1990) Natural history of mixed chimerism after bone marrow transplantation with CD6-depleted allogeneic marrow: a stable equilibrium. Blood, 75, 296-304.
32. Slavin, S., Naparstek, E., Ackerstein, A., Samuel, S., Kapelushnik, J., Brautbar, C. & Or, R. (1996) Allogeneic cell therapy with donor peripheral blood cells and recombinant human interleukin-2 to treat leukemia relapse after allogeneic bone marrow transplantation. Blood, 87, 2195-2204.
33. Socie, G., Lawler, M., Gluckman, E., McCann, S.R. & Brison, O. (1995) Studies on hemopoietic chimerism following allogeneic bone marrow transplantation in the molecular biology era. Leukemia Research, 19, 497-504.
34. Sondel, P.M., Hank, J.A., Molenda, J., Blank, J., Borcherding, W., Longo, W., Trigg. M.E., Hong, R. & Bozdech, M.J. (1985) Relapse of host leukemia lymphoblasts following engraftment by an HLA-mismatched marrow transplant: mechanisms of escape from the 'graft versus leukemia' effect. Experimental Hematalogy, 13, 782-790.
35. Truitt, R.L. & Atasoylu, A.A. (1991) Impact of pretransplant conditioning and donor T cells on chimerism, graft-versus-host disease, graft-versus-leukemia reactivity, and tolerance after bone marrow transplantation. Blood, 77, 2515-2523.